Biotech Values

[DewDiligence]

AGN acquires (private) LifeCell for $2.9B cash:

http://www.prnewswire.com/news-releases/allergan-to-acquire-acelity-lp-incs-lifecell-corporation-for-29-billion-300381947.html

The acquisition combines LifeCell's novel, regenerative medicines business, including its high-quality and durable portfolio of dermal matrix products with Allergan's leading portfolio of medical aesthetics, breast implants and tissue expanders. Together, these product lines will create a world class aesthetic and regenerative medicine business providing significant opportunity to enhance the overall product offering for plastic and general surgery customers globally. Allergan anticipates the LifeCell assets will generate approximately $450 million in 2016 revenue, growing at a mid-single digit rate, approximately 75% gross margin and approximately 40% operating margin in 2016.

LifeCell is currently a wholly owned subsidiary of Acelity L.P.